Cover Image
市場調查報告書

先進創傷護理的全球市場的未來展望 (2018年)

Global Advanced Wound Care Market Outlook 2018

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 324704
出版日期 內容資訊 英文 55 Pages
訂單完成後即時交付
價格
Back to Top
先進創傷護理的全球市場的未來展望 (2018年) Global Advanced Wound Care Market Outlook 2018
出版日期: 2015年02月01日 內容資訊: 英文 55 Pages
簡介

隨全球各國平均壽命延長,還有糖尿病等的文明病的患者增加,足部慢性潰瘍等難治療疾病的患病人數也增加了。隨這樣的創傷的發生數量的增加,和傷口護理相關理解的加深,開發了先進創傷護理 (AWC) 產品、治療藥。這樣的產品、治療藥剛開始很高價,不過,因為恢復期間很短,使住院期間縮短,導致整體治療成本削減。全球先進創傷護理的市場規模,2013年達到68億美元,2018年推算達91億美元。

本報告提供全球的先進創傷護理 (AWC: Advanced Wound Care) 市場相關分析、技術、產品概要和整體市場結構、市場促進、阻礙因素、最新的市場趨勢和今後發展的方向性、市場規模趨勢預測 (今後5年份)、主要企業簡介 (產業概要、市場佔有率、財務指標、競爭力 (SWOT分析)) 等調查、考察。

第1章 分析師的見解

第2章 調查手法

第3章 簡介

  • 創傷的種類
    • 潰瘍
    • 燒燙傷
    • 外科性創傷
  • 先進創傷護理 (AWC) :產品、技術
    • 薄膜敷料(薄膜繃帶)
    • 海綿敷料 (發泡繃帶)
    • 膠原蛋白 (膠原)
    • 藻酸鹽 (藻酸鹽)
    • 親水膠體
    • 水凝膠
    • 氧氣療法/高壓氧氣療法設備
    • 電磁療法用設備
    • 傷口負壓治療 (NPWT)

第4章 市場推動因素與課題

  • 比傳統技術的優點大,促進AWC市場成長
  • 在醫院的AWC的引進案例的增加使市場成長
  • 糖尿病的發病者數增加促進市場成長
  • 醫療預算的削減,及醫療費償付額低,成為AWC普及的大障礙

第5章 市場概要

  • 全球創傷護理市場
  • 全球先進創傷護理市場

第6章 市場趨勢與發展

  • 高壓氧氣療法的引進數量的增加
  • 生理活性肽:AWC領域下次的「一著」
  • 智慧敷料:傷口護理的新尺寸
  • 使用了奈米技術,創傷護理演變至新水準

第7章 競爭環境

  • 全球AWC市場上主要企業的市場佔有率
  • 簡介
    • Convatec
    • Centaur Guernsey L.P. Inc.
    • Smith & Nephew
    • Molnlycke Health Care
    • Coloplast
    • Hartmann Group
    • Derma Sciences
    • Integra LifeSciences

第8章 未來預測

圖表一覽

目錄

Increased life expectancy and growing incidence of lifestyle associated disorders such as Diabetes, has resulted in increased prevalence of hard to heal wounds such as chronic foot ulcers. The inclining burden of such wounds and improved understanding of wound healing has led to the emergence of Advanced Wound Care (AWC) products and therapies. These products and therapies, though expensive initially, result in faster recoveries and hence, shorter hospital stays, resulting in overall reduced costs.

A new research study conducted by RNCOS, "Global Advanced Wound Care Market Outlook 2018", reveals that the market, which was worth US$ 6.8 Billion in 2013, is expected to grow to US$ 9.1 Billion by 2018. The report has been divided into numerous sections that deal with the various aspects of the AWC market.

The reader is first introduced to the various types of wounds, which have been broadly categorized into Ulcers, Burns and Surgical Wounds. The next section deals with the various AWC products and technologies that are currently available in the market along with a brief explanation of their modus operandi. The market section starts with an overview of the global wound care market and its current and future geographical breakdown. This is followed by a detailed analysis of the global AWC market and its current share in the total wound care industry. The next section broadly segments the AWC industry into AWC Dressings and AWC Technologies.

The report then talks about the various applications and technological trends that have been a part of the industry. Some of these trends include the rise of Hyberbaric Oxygen Therapy, uptake of peptide bioactives and the emergence of smart dressings. The market is subject to various drivers as well as challenges which have and will continue to mould it. It is expected that the numerous advantages offered by AWC over its traditional counterpart will propel the growth of the market. However, the high cost of equipment, shrinking budgets, low awareness and reimbursement issues may act as bottlenecks for growth.

This report also highlights key players and their current market share in the AWC domain. For every player, a brief business overview, geographic revenue break up and segment wise revenue break up along with key financials have been provided. A strength and weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of the players. At the end, a section has been dedicated to the Future Outlook, which discusses the various upcoming technologies which will further help in advancing the healing process. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the AWC.

Table of Contents

1. Analyst View

2. Research Methodology

3. An Introduction

  • 3.1 Types of Wounds
    • 3.1.1 Ulcers
    • 3.1.2 Burns
    • 3.1.3 Surgical Wounds
  • 3.2 Advanced Wound Care (AWC) - Products and Technologies
    • 3.2.1 Film Dressings
    • 3.2.2 Foam Dressings
    • 3.2.3 Collagen
    • 3.2.4 Alginates
    • 3.2.5 Hydrocolloids
    • 3.2.6 Hydrogels
    • 3.2.7 Oxygen and Hyperbaric Oxygen Equipment
    • 3.2.8 Electromagnetic Therapy Devices
    • 3.2.9 Negative Pressure Wound Therapy

4. Drivers and Challenges

  • 4.1 Significant Benefits over Traditional Counterparts to Drive the Growth of AWC
  • 4.2 Increased Hospital Adoption of AWC to Boost the Market
  • 4.3 Rising Incidence of Diabetes to Spur Market Growth
  • 4.4 Shrinking Healthcare Budgets and Low Reimbursement Act as Major Hurdles for AWC

5. Market Overview

  • 5.1 Global Wound Care Market
  • 5.2 Global Advanced Wound Care Market

6. Market Trends and Developments

  • 6.1 Rise in Adoption of Hyperbaric Oxygen Therapy
  • 6.2 Peptide Bioactives: The next 'it' thing in the field of AWC
  • 6.3 Smart Dressings: Adding a New Dimension to Wound Healing
  • 6.4 Taking Wound Care to a New Level with Nanotechnology

7. Competitive Landscape

  • 7.1 Share of Major Players in the AWC Market
  • 7.2 Profiles
    • 7.2.1 Convatec
    • 7.2.2 Centaur Guernsey L.P. Inc.
    • 7.2.3 Smith & Nephew
    • 7.2.4 Mölnlycke Health Care
    • 7.2.5 Coloplast
    • 7.2.6 Hartmann Group
    • 7.2.7 Derma Sciences
    • 7.2.8 Integra LifeSciences

8. Future Outlook

List of Figures:

  • Figure 4-1: Global - Wound Care Market (Billion US$), 2013-2018
  • Figure 4-2: Global - Wound Care Market by Geography (%), 2013
  • Figure 4-3: Global - Wound Care Market by Geography (%), 2018
  • Figure 4-4: Global - Advanced Wound Care Market (Billion US$), 2013-2018
  • Figure 4-5: Global - Share of AWC in the Total Wound Care Market (%), 2013 & 2018
  • Figure 4-6: Global - AWC Market by Product Segment (%), 2013
  • Figure 7-1: Convatec - Break up of Revenue by Industry Segment (%), 2013
  • Figure 7-2: Convatec - AWC Revenue (Million US$), 2011-2013
  • Figure 7-3: Centaur Guernsey - Break up of Revenue by Industry Segment (%), 2013
  • Figure 7-4: Centaur Guernsey - Break up of Revenue by Geographic Segment (%), 2013
  • Figure 7-5: Centaur Guernsey - AWC Revenue (Billion US$), 2011-2013
  • Figure 7-6: Smith & Nephew - Break up of Revenue by Geographic Segment (%), 2013
  • Figure 7-7: Smith & Nephew - Break up of Revenue by Industrial Segment (%), 2013
  • Figure 7-8: Smith & Nephew - Break up of AWC Revenue by Segment (%), 2013
  • Figure 7-9: Smith & Nephew - AWC Revenue (Billion US$), 2011-2013
  • Figure 7-10: Coloplast - Break up of Revenue by Geographic Segment (%), 2013
  • Figure 7-11: Coloplast - Break up of Revenue by Industrial Segment (%), 2013
  • Figure 7-12: Coloplast - AWC Revenue (Billion DKK), 2011-2013
  • Figure 7-13: Hartmann Group - Break up of Revenue by Industrial Segment (%), 2013
  • Figure 7-14: Hartmann Group - Break up of Revenue by Geographical Segment (%), 2013
  • Figure 7-15: Integra LifeSciences - Break up of Revenue by Geographical Segment (%), 2013
  • Figure 7-16: Integra LifeSciences - Break up of US Revenue by Industrial Segment (%), 2013

List of Tables:

  • Table 3-1: Benefits of Advanced Wound Care
  • Table 7-1: Global - Share of Major Players in the AWC Market (%), 2013
  • Table 7-2: Convatec - Key Financials (Million US$), 2011-2013
  • Table 7-3: Convatec - Strengths and Weaknesses
  • Table 7-4: Centaur Guernsey - Key Financials (Million US$), 2011-2013
  • Table 7-5: Centaur Guernsey - Strengths and Weaknesses
  • Table 7-6: Smith & Nephew - Key Financials (Million US$), 2011-2013
  • Table 7-7: Smith & Nephew - Strengths and Weaknesses
  • Table 7-8: Mölnlycke Health Care - Strengths and Weaknesses
  • Table 7-9: Coloplast - Key Financials (Million DKK), 2011-2013
  • Table 7-10: Coloplast - Strengths and Weaknesses
  • Table 7-11: Hartmann Group - Key Financials (Million EUR), 2011-2013
  • Table 7-12: Hartmann Group - Strengths and Weaknesses
  • Table 7-13: Derma Sciences - Key Financials (Million US$), 2011-2013
  • Table 7-14: Derma Sciences - Strengths and Weaknesses
  • Table 7-15: Integra LifeSciences - Key Financials (Million US$), 2011-2013
  • Table 7-16: Integra LifeSciences - Strengths and Weaknesses
Back to Top